Related Scientific Literature

• Clinical evaluation of a SARS-CoV-2 RT-PCR assay on a fully automated system for rapid on-demand testing in the hospital setting
• Test Agreement Between Roche Cobas 6800 and Cepheid GeneXpert Xpress SARS-CoV-2 Assays at High Cycle Threshold Ranges
• Failure of the cobas(R) SARS-CoV-2 (Roche) E-gene assay is associated with a C-to-T transition at position 26340 of the SARS-CoV-2 genome
• FACT- Frankfurt adjusted COVID-19 testing- a novel method enables high-throughput SARS-CoV-2 screening without loss of sensitivity
• Comparison of Commercially Available and Laboratory Developed Assays for in vitro Detection of SARS-CoV-2 in Clinical Laboratories
• Comparison of Cepheid Xpert Xpress and Abbott ID Now to Roche cobas for the Rapid Detection of SARS-CoV-2
• Diagnostic Testing for Severe Acute Respiratory Syndrome-Related Coronavirus-2: A Narrative Review
• Comparison of Commercially Available and Laboratory Developed Assays for in vitro Detection of SARS-CoV-2 in Clinical Laboratories
• Comparison of Two High-Throughput Reverse Transcription-Polymerase Chain Reaction Systems for the Detection of Severe Acute Respiratory Syndrome Coronavirus 2
• Humoral immune response and prolonged PCR positivity in a cohort of 1343 SARS-CoV 2 patients in the New York City region
• Diagnostic performance of COVID-19 serology assays
• COVID-19 Special Column: Principles Behind the Technology for Detecting SARS-CoV-2, the Cause of COVID-19
• Diagnostics for SARS-CoV-2 detection: A comprehensive review of the FDA-EUA COVID-19 testing landscape
• Detection of COVID-19: A review of the current literature and future perspectives
• The different tests for the diagnosis of COVID-19 - A review in Brazil so far
• Challenges in Laboratory Diagnosis of the Novel Coronavirus SARS-CoV-2
• Clinical evaluation of self-collected saliva by RT-qPCR, direct RT-qPCR, RT-LAMP, and a rapid antigen test to diagnose COVID-19
• Comparison of two commercial platforms and a laboratory developed test for detection of SARS-CoV-2 RNA
• Clinical Sensitivity and Interpretation of PCR and Serological COVID-19 Diagnostics for Patients Presenting to the Hospital
• Current and Perspective Diagnostic Techniques for COVID-19
• Exploring alternative swabs for use in SARS-CoV-2 detection from the oropharynx and anterior nares
• Molecular and Immunological Diagnostic Tests of COVID-19: Current Status and Challenges
• COVID-19: a meta-analysis of diagnostic test accuracy of commercial assays registered in Brazil
• Clinical evaluation of the BioFire® Respiratory Panel 2.1 and detection of SARS-CoV-2
• Clinical performance of sars-cov-2 molecular tests
• In vitro diagnostics of coronavirus disease 2019: Technologies and application
• Comparison of SARS-CoV-2 detection from nasopharyngeal swab samples by the Roche cobas 6800 SARS-CoV-2 test and a laboratory-developed real-time RT-PCR test
• Molecular, serological, and biochemical diagnosis and monitoring of COVID-19: IFCC taskforce evaluation of the latest evidence
• Evaluation of transport media and specimen transport conditions for the detection of sars-cov-2 by use of real-time reverse transcription-PCR
• International external quality assessment for SARS-CoV-2 molecular detection and survey on clinical laboratory preparedness during the COVID-19 pandemic, April/May 2020
• Brief validation of the novel GeneXpert Xpress SARS-CoV-2 PCR assay
• Comparison of the analytical sensitivity of seven commonly used commercial SARS-CoV-2 automated molecular assays
• COVID-19 symptoms predictive of healthcare workers' SARS-CoV-2 PCR results
• Testing For SARS-CoV-2: The Day the World Turned its Attention to the Clinical Laboratory
• Detection of low levels of SARS-CoV-2 RNA from nasopharyngeal swabs using three commercial molecular assays
• Diagnostic accuracy of Augurix COVID-19 IgG serology rapid test
• Clinical evaluation of five different automated SARS-CoV-2 serology assays in a cohort of hospitalized COVID-19 patients
• Comparison of Cepheid Xpert Xpress and Abbott ID Now to Roche cobas for the Rapid Detection of SARS-CoV-2
• Lower nasopharyngeal viral load during the latest phase of COVID-19 pandemic in a Northern Italy University Hospital
• Extraction-free SARS-CoV-2 detection by rapid RT-qPCR universal for all primary respiratory materials
• Assay Techniques and Test Development for COVID-19 Diagnosis.
• Validation of a commercially available SARS-CoV-2 serological immunoassay
• Lack of sensitivity of an IVD/CE-labelled kit targeting the S gene for detection of SARS-CoV-2
• Clinical Evaluation and Utilization of Multiple Molecular In Vitro Diagnostic Assays for the Detection of SARS-CoV-2
• Clinical predictors and timing of cessation of viral RNA shedding in patients with COVID-19
• Method comparison of SARS-CoV-2 serology assays involving three commercially available platforms and a novel in-house developed enzyme-linked immunosorbent assay
• Clinical performance and sample freeze-thaw stability of the cobas 6800 SARS-CoV-2 assay for the detection of SARS-CoV-2 in oro-/nasopharyngeal swabs and lower respiratory specimens
• Meta-analysis of the clinical performance of commercial SARS-CoV-2 nucleic acid, antigen and antibody tests up to 22 August 2020
• Evaluation of the EUROIMMUN Anti-SARS-CoV-2 ELISA Assay for detection of IgA and IgG antibodies.
• Multicenter comparison of the Cobas 6800 system with the RealStar RT-PCR kit for the detection of SARS-CoV-2
• The Detection of SARS-CoV-2 using the Cepheid Xpert Xpress SARS-CoV-2 and Roche 2 cobas SARS-CoV-2 Assays
• Test Agreement between Roche Cobas 6800 and Cepheid GeneXpert Xpress SARS-CoV-2 Assays at High Cycle Threshold Ranges
• Analytical performance of lateral flow immunoassay for SARS-CoV-2 exposure screening on venous and capillary blood samples
• Pushing beyond specifications: Evaluation of linearity and clinical performance of a fully automated SARS-CoV-2 RT-PCR assay for reliable quantification in blood and other materials outside recommendations
• SARS-CoV-2 sample-to-answer nucleic acid testing in a tertiary care emergency department: evaluation and utility
• Evaluation of the COVID-19 IgG/IgM Rapid Test from Orient Gene Biotech.
• Performance of Abbott ID Now COVID-19 Rapid Nucleic Acid Amplification Test Using Nasopharyngeal Swabs Transported in Viral Transport
• Rapid Implementation of Severe Acute Respiratory Syndrome Coronavirus 2 Emergency Use Authorization RT-PCR Testing and Experience at an Academic Medical Institution
• A Rapid High-Sensitivity SARS-CoV-2 Nucleocapsid Immunoassay to Aid Diagnosis of Acute COVID-19 at the Point of Care: A Clinical Performance
• Clinical Evaluation of the cobas SARS-CoV-2 Test and a Diagnostic Platform Switch during 48 Hours in the Midst of the COVID-19